These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5610155)

  • 1. [The level of fibrin stabilizing factor in the blood of patients with disorder of the coronary circulation].
    Panchenko VM; Molchanova LV
    Klin Med (Mosk); 1967 Oct; 45(10):69-72. PubMed ID: 5610155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arteriosclerosis as a main factor in blood coagulation disorders in patients with hypertensive disease].
    Dashtaiants GA; Andrushchenko EV
    Vrach Delo; 1973 Jan; 1():14-6. PubMed ID: 4722275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemorrhagic disease due to a defect of the fibrin stabilizing factor].
    Ottaviani P; Mandelli F; Fontana L; Morelli R
    Recenti Prog Med; 1966 May; 40(5):377-407. PubMed ID: 6012638
    [No Abstract]   [Full Text] [Related]  

  • 4. [State of vascular permeability and some indices of the blood anticoagulation system in arteriosclerosis].
    Malaia LT; Pavlichenko AK
    Vrach Delo; 1968 Jan; 1():15-8. PubMed ID: 5672353
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolysis incidence in arteriosclerosis-induced illnesses as well as in arteriosclerosis positive and negative syntropic diseases].
    Schulz FH; Bach G; Künzel A
    Dtsch Gesundheitsw; 1970 Apr; 25(15):682-4. PubMed ID: 5483709
    [No Abstract]   [Full Text] [Related]  

  • 6. [The daily rhythm of blood coagulation in patients with intermediate forms of ischemic heart disease].
    Perepelkin EG
    Klin Med (Mosk); 1972 Dec; 50(12):77-81. PubMed ID: 4660504
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thromboelastography in coronary heart disease: evaluations provided of the blood coagulation situation; indications for therapy].
    Chiesa FT
    G Gerontol; 1971 Oct; 19(10):800-4. PubMed ID: 5140488
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma fibrin-stabilizing factor activity in acquired disease.
    Walls WD; Losowsky MS
    Br J Haematol; 1968 Sep; 15(3):327. PubMed ID: 5681498
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong.
    Chan JC; Kwok MM; Cockram CS; Prematilleke MN; Tomlinson B; Critchley JA
    Singapore Med J; 1993 Apr; 34(2):145-7. PubMed ID: 8266156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aggregation state of the blood of patients in the early period after surgery with artificial blood circulation].
    Dement'eva II; Roĭtman EV; Eremenko AA; Leonova SF
    Anesteziol Reanimatol; 1994; (6):35-9. PubMed ID: 7733477
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of thrombophilic syndromes. I. Coagulation changes in coronary arteriosclerosis, cerebral arteriosclerosis and peripheral artery arteriosclerosis].
    Neri Serneri GG; Paoletti P; Silvestrini E; Masotti G
    Riv Crit Clin Med; 1968; 68(3):211-37. PubMed ID: 5737876
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulopathies associated with lymphoproliferative disorders.
    Boggio L; Green D
    Curr Hematol Rep; 2004 Jan; 3(1):1-4. PubMed ID: 14695843
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
    Lowe GD; Rumley A; McMahon AD; Ford I; O'Reilly DS; Packard CJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1529-34. PubMed ID: 15205218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulation disorders without hemorrhagic diathesis due to delayed aggregration of fibrin molecules].
    von Felten A; Duckert F; Frick P
    Schweiz Med Wochenschr; 1965 Oct; 95(43):1453-6. PubMed ID: 5880932
    [No Abstract]   [Full Text] [Related]  

  • 16. [Importance of fibrin-fibrinogen degradation products in the pathogenesis of a coagulopathy in leukemias].
    Krasik IaD; Fedorova ZD; Elizarova AI; Rozanova LM; Bazhenov EL
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):13-8. PubMed ID: 6929066
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies of thrombophilic syndromes. II. Preliminary research on the behavior of the plasmatic inhibitor of the product of the contact reaction in coronary, cerebral and peripheral arteriosclerosis].
    Neri Serneri GG; Paoletti P; Silvestrini E; Masotti G
    Riv Crit Clin Med; 1968; 68(4):289-323. PubMed ID: 5746286
    [No Abstract]   [Full Text] [Related]  

  • 18. Two cases of haemorrhagic disease arising from fibrin stabilizing factor deficiency.
    Ottaviani P; Mandelli F
    Hemostase; 1966; 6(5):317-24. PubMed ID: 5999890
    [No Abstract]   [Full Text] [Related]  

  • 19. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of newly developed technology in blood coagulation disorders].
    Matsuo T
    Rinsho Byori; 2002 May; 50(5):506-12. PubMed ID: 12078050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.